RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today

4
2
Favorite

RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today

investorplace2021-04-09

Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Report

Comment（2）

RWRW
·2021-04-09
Penny stock to invest
Reply
Like
Report
VivalaRan
·2021-04-09
Hmmmmm
Reply
Like
Report

Most Discussed

7x24

All

Terms and Conditions·Privacy Policy

Company: TTMF Limited. Tech supported by Xiangshang Yixin.

Email：uservice@ttm.financial

{"i18n":{"language":"en_US"},"data":{"share":"https://ttm.financial/m/news/1108224926?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2021-04-09 16:21","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1108224926","market":"us","top_or_hot":-1,"title":"RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today","media":"investorplace","content":"<div>\n<p>Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the ...</p>\n\n<a href=\"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/\">Source Link</a>\n\n</div>\n","source":"lsy1606302653667","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the ...</p>\n\n<a href=\"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RGBP","symbol_name":"Regen Biopharma, Inc.","start_time":0,"source_url":"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/","article_id":"1108224926","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1108224926","pubTimestamp":1617956482,"sourceInfo":{"source_id":"lsy1606302653667","name":"InvestorPlace"},"weMediaInfo":null,"summary":"Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’","collect":0,"end_time":0,"defaultTopTitle":"investorplace.com","property":[],"viewcount":null,"language":"en","relate_stocks":{"RGBP":"Regen Biopharma, Inc."},"translate_title":"RGBP股票：名不见经传的瑞根生物制药为何今日大涨800%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RGBP":0.9},"content_text":"Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the companyannounceda licensing deal for its pancreatic cancer treatment.Source: ShutterstockFor any stock trading near the “triple zero” range, such moves are possible. This is a relatively microscopic company with a market capitalization of only $10 million right now. Put in perspective, yesterday’s market cap would have been closer to the $1 million mark.Accordingly, there’s really no telling how high the volatility could be from here. Indeed, today’s move is an indication investors are bullish on this announcement.So, let’s dive into what was announced and why investors are piling into RGBP stock today.The Deal That’s Sending RGBP Stock Soaring TodayWhile the deal was initiallyagreed toyesterday, today, Regenreleasedits official 8-K following the announcement.Regen has entered into a licensing agreement withOncology Pharma(OTCMKTS:ONPH) whereby ONPH will gain access to Regen’s intellectual property “pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.” At the time of writing, ONPH stock was up 8% on the news.According to the 8K:“As consideration to Regen for the rights and license granted pursuant to the Agreement Licensee shall:pay to Regen a nonrefundable fee of $55,000 no later than April 20, 2021;pay to Regen royalties equal to 5% of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter;and pay to Regen ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Regen receives payment.”Indeed, this deal sounds beneficial for RGBP shareholders today. As with other speculative penny stocks, chatter onReddithas picked up on RGBP stock.","kind":null,"is_publish_news":true,"is_publish_highlight":true,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[{"id":348440987,"gmtCreate":1617956689449,"gmtModify":1704705283840,"author":{"id":"3575775447152697","authorId":"3575775447152697","name":"RWRW","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3575775447152697","authorIdStr":"3575775447152697"},"htmlText":"Penny stock to invest","listText":"Penny stock to invest","text":"Penny stock to invest","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348440987","repostId":1108224926,"repostType":4,"repost":{"id":"1108224926","pubTimestamp":1617956482,"share":"https://ttm.financial/m/news/1108224926?lang=&edition=fundamental","pubTime":"2021-04-09 16:21","market":"us","language":"en","title":"RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1108224926","media":"investorplace","summary":"Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’","content":"<p>Little-known penny stock&nbsp;<b>Regen Biopharma</b>(OTCMKTS:<b><u>RGBP</u></b>) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the companyannounceda licensing deal for its pancreatic cancer treatment.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/12da4576b3bdfcdc76380ed3e4577379\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: Shutterstock</span></p><p>For any stock trading near the “triple zero” range, such moves are possible. This is a relatively microscopic company with a market capitalization of only $10 million right now. Put in perspective, yesterday’s market cap would have been closer to the $1 million mark.</p><p>Accordingly, there’s really no telling how high the volatility could be from here. Indeed, today’s move is an indication investors are bullish on this announcement.</p><p>So, let’s dive into what was announced and why investors are piling into RGBP stock today.</p><p>The Deal That’s Sending RGBP Stock Soaring Today</p><p>While the deal was initiallyagreed toyesterday, today, Regenreleasedits official 8-K following the announcement.</p><p>Regen has entered into a licensing agreement with<b>Oncology Pharma</b>(OTCMKTS:<b><u>ONPH</u></b>) whereby ONPH will gain access to Regen’s intellectual property “pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.” At the time of writing, ONPH stock was up 8% on the news.</p><p>According to the 8K:</p><p>“As consideration to Regen for the rights and license granted pursuant to the Agreement Licensee shall:</p><ul><li>pay to Regen a nonrefundable fee of $55,000 no later than April 20, 2021;</li><li>pay to Regen royalties equal to 5% of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter;</li><li>and pay to Regen ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Regen receives payment.”</li></ul><p>Indeed, this deal sounds beneficial for RGBP shareholders today. As with other speculative penny stocks, chatter onReddithas picked up on RGBP stock.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the ...</p>\n\n<a href=\"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RGBP":"Regen Biopharma, Inc."},"source_url":"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108224926","content_text":"Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the companyannounceda licensing deal for its pancreatic cancer treatment.Source: ShutterstockFor any stock trading near the “triple zero” range, such moves are possible. This is a relatively microscopic company with a market capitalization of only $10 million right now. Put in perspective, yesterday’s market cap would have been closer to the $1 million mark.Accordingly, there’s really no telling how high the volatility could be from here. Indeed, today’s move is an indication investors are bullish on this announcement.So, let’s dive into what was announced and why investors are piling into RGBP stock today.The Deal That’s Sending RGBP Stock Soaring TodayWhile the deal was initiallyagreed toyesterday, today, Regenreleasedits official 8-K following the announcement.Regen has entered into a licensing agreement withOncology Pharma(OTCMKTS:ONPH) whereby ONPH will gain access to Regen’s intellectual property “pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.” At the time of writing, ONPH stock was up 8% on the news.According to the 8K:“As consideration to Regen for the rights and license granted pursuant to the Agreement Licensee shall:pay to Regen a nonrefundable fee of $55,000 no later than April 20, 2021;pay to Regen royalties equal to 5% of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter;and pay to Regen ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Regen receives payment.”Indeed, this deal sounds beneficial for RGBP shareholders today. As with other speculative penny stocks, chatter onReddithas picked up on RGBP stock.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":348457600,"gmtCreate":1617956608300,"gmtModify":1704705282707,"author":{"id":"3573442142945386","authorId":"3573442142945386","name":"VivalaRan","avatar":"https://static.tigerbbs.com/bbdf1f2a57583bc2d6a9cae2d7c9b451","vip":1,"crmLevel":2,"crmLevelSwitch":0,"idStr":"3573442142945386","authorIdStr":"3573442142945386"},"htmlText":"Hmmmmm","listText":"Hmmmmm","text":"Hmmmmm","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/348457600","repostId":1108224926,"repostType":4,"repost":{"id":"1108224926","pubTimestamp":1617956482,"share":"https://ttm.financial/m/news/1108224926?lang=&edition=fundamental","pubTime":"2021-04-09 16:21","market":"us","language":"en","title":"RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today","url":"https://stock-news.laohu8.com/highlight/detail?id=1108224926","media":"investorplace","summary":"Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’","content":"<p>Little-known penny stock&nbsp;<b>Regen Biopharma</b>(OTCMKTS:<b><u>RGBP</u></b>) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the companyannounceda licensing deal for its pancreatic cancer treatment.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/12da4576b3bdfcdc76380ed3e4577379\" tg-width=\"300\" tg-height=\"169\" referrerpolicy=\"no-referrer\"><span>Source: Shutterstock</span></p><p>For any stock trading near the “triple zero” range, such moves are possible. This is a relatively microscopic company with a market capitalization of only $10 million right now. Put in perspective, yesterday’s market cap would have been closer to the $1 million mark.</p><p>Accordingly, there’s really no telling how high the volatility could be from here. Indeed, today’s move is an indication investors are bullish on this announcement.</p><p>So, let’s dive into what was announced and why investors are piling into RGBP stock today.</p><p>The Deal That’s Sending RGBP Stock Soaring Today</p><p>While the deal was initiallyagreed toyesterday, today, Regenreleasedits official 8-K following the announcement.</p><p>Regen has entered into a licensing agreement with<b>Oncology Pharma</b>(OTCMKTS:<b><u>ONPH</u></b>) whereby ONPH will gain access to Regen’s intellectual property “pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.” At the time of writing, ONPH stock was up 8% on the news.</p><p>According to the 8K:</p><p>“As consideration to Regen for the rights and license granted pursuant to the Agreement Licensee shall:</p><ul><li>pay to Regen a nonrefundable fee of $55,000 no later than April 20, 2021;</li><li>pay to Regen royalties equal to 5% of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter;</li><li>and pay to Regen ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Regen receives payment.”</li></ul><p>Indeed, this deal sounds beneficial for RGBP shareholders today. As with other speculative penny stocks, chatter onReddithas picked up on RGBP stock.</p>","source":"lsy1606302653667","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>RGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nRGBP Stock: Why Little-Known Regen Biopharma Is Soaring 800% Today\n</h2>\n\n<h4 class=\"meta\">\n\n\n2021-04-09 16:21 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/><strong>investorplace</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the ...</p>\n\n<a href=\"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"RGBP":"Regen Biopharma, Inc."},"source_url":"https://investorplace.com/2021/04/rgbp-stock-why-little-known-regen-biopharma-is-soaring-800-today/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1108224926","content_text":"Little-known penny stock Regen Biopharma(OTCMKTS:RGBP) has soared 800% at the time of writing. That’s not a typo. Investors in RGBP stock have booked an 8-bagger in this stock today as the companyannounceda licensing deal for its pancreatic cancer treatment.Source: ShutterstockFor any stock trading near the “triple zero” range, such moves are possible. This is a relatively microscopic company with a market capitalization of only $10 million right now. Put in perspective, yesterday’s market cap would have been closer to the $1 million mark.Accordingly, there’s really no telling how high the volatility could be from here. Indeed, today’s move is an indication investors are bullish on this announcement.So, let’s dive into what was announced and why investors are piling into RGBP stock today.The Deal That’s Sending RGBP Stock Soaring TodayWhile the deal was initiallyagreed toyesterday, today, Regenreleasedits official 8-K following the announcement.Regen has entered into a licensing agreement withOncology Pharma(OTCMKTS:ONPH) whereby ONPH will gain access to Regen’s intellectual property “pertaining to mRNA to be used in developing a therapy for treating pancreatic cancer.” At the time of writing, ONPH stock was up 8% on the news.According to the 8K:“As consideration to Regen for the rights and license granted pursuant to the Agreement Licensee shall:pay to Regen a nonrefundable fee of $55,000 no later than April 20, 2021;pay to Regen royalties equal to 5% of the Net Sales as Net Sales are defined in the Agreement of any Licensed Products in a quarter;and pay to Regen ten percent (10%) of all consideration (in the case of in-kind consideration, at fair market value as monetary consideration) received by Licensee from sublicensees, excluding royalties from sublicensees based on Net Sales of any Licensed Products for which Regen receives payment.”Indeed, this deal sounds beneficial for RGBP shareholders today. As with other speculative penny stocks, chatter onReddithas picked up on RGBP stock.","news_type":1},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"hasMoreComments":true,"newsSizeData":{"likeSize":4,"commentSize":2,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false}}